Senate Approves Renewal of Breast Cancer Research Stamp

Washington—Legislation introduced by U.S. Senators Dianne Feinstein (D-Calif.) and Kay Bailey Hutchison (R-Texas) to extend the sale of the highly successful Breast Cancer Research Stamp unanimously passed the U.S. Senate. The legislation is cosponsored by a bipartisan coalition of 66 Senators.

The sale of each 55-cent stamp designates 11 cents to breast cancer research. Since its introduction in 1998, more than 924 million breast cancer research stamps have been sold – raising over $74 million for breast cancer research.

Extending the authorization of the Breast Cancer Research Stamp, S. 384, would raise additional funds for breast cancer for another four years – until 2015. Without Congressional action, the stamp will expire on December 31.

“The highly successful Breast Cancer Research Stamp has raised over $74 million for research, and it is now less than a month away from expiring,” said Senator Feinstein. “I am pleased that so many senators on both sides of the aisle came together for such an important cause, and I urge the House to pass this bill quickly so that this unique stamp can continue. Breast cancer is the second most common cause of cancer deaths among women in the Unites States. This stamp helps scientific breakthroughs ensure more women survive this deadly disease.”

“The Breast Cancer Research Stamp has been a vital tool in ensuring that breast- cancer patients become breast-cancer survivors,” said Senator Hutchison. “The stamp has raised, through voluntary contributions, tens of millions of dollars that have supported innovative research that has helped save lives. And, I believe that with enough resources, the fight against breast cancer can be won.”